Synsepalum dulcificum
Botanicalexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Aug 18, 2008 (NCT04629560)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05273307 | Phase 3 | Mar 4, 2022 | Mount Zion Health Fund, University of California, San Francisco |
| NCT05468411 | N/A | Nov 1, 2019 | City University of New York |
| NCT04629560 | Early Phase 1 (Phase 1) | Aug 18, 2008 | Icahn School of Medicine at Mount Sinai, Mt. Sinai Medical Center, Miami |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| City University of New York | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Mount Zion Health Fund | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Mt. Sinai Medical Center, Miami | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2022 |
5 organizations
Page 1 / 1